Literature DB >> 9574710

Comparison of methods of identifying Helicobacter hepaticus in B6C3F1 mice used in a carcinogenesis bioassay.

J G Fox1, J A MacGregor, Z Shen, X Li, R Lewis, C A Dangler.   

Abstract

In a long-term rodent bioassay evaluating the carcinogenicity of triethanolamine, there was equivocal evidence of carcinogenic activity in male B6C3F1 mice, based on a marginal increase in the number of hepatocellular adenomas and hepatoblastomas. Interpretation was complicated by the presence of Helicobacter hepaticus in selected silver-stained liver sections which also had histological evidence of karyomegaly and oval cell hyperplasia. An increase in numbers of liver tumors, as evidence of carcinogenic activity, was also noted in female mice. However, H. hepaticus was not considered a complicating factor, because the livers of the female mice did not have histological features compatible with H. hepaticus infection. A retrospective analysis of 51 liver tissue samples from the original carcinogenicity study was conducted to determine the incidence of H. hepaticus infection and to evaluate different diagnostic approaches for assessing the presence of H. hepaticus in livers lacking characteristic lesions. In an initial evaluation of seven mice with liver tumors, argyrophilic bacteria resembling H. hepaticus were observed in liver sections, associated with characteristic liver lesions of hepatocytic karyomegaly and oval cell hyperplasia. Frozen liver tissue was available from four of these mice; all were confirmed to be infected with H. hepaticus by culture and PCR. In a larger subsequent analysis using frozen liver tissues from 44 mice without characteristic hepatic lesions, H. hepaticus-specific DNA was amplified from the livers of 21 of 44 of the mice (47%), compared to 14 of 44 of the mice (32%) having H. hepaticus cultured from their frozen liver tumors. The results of H. hepaticus culture and H. hepaticus-specific PCR concurred (i.e., both positive and negative results) in 84% of the cases. Microscopic detection of immunofluorescence-labeled or silver-stained bacteria in liver sections was relatively insensitive compared to either culture or PCR detection. This study confirms the widespread prevalence of H. hepaticus in mice, its potential to confound experimental results, and the need to include diagnostic testing for H. hepaticus in a murine health monitoring program.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9574710      PMCID: PMC104833          DOI: 10.1128/JCM.36.5.1382-1387.1998

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Carcinogenicity of triethanolamine in mice and its mutagenicity after reaction with sodium nitrite in bacteria.

Authors:  H Hoshino; H Tanooka
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

2.  Chronic toxicity carcinogenicity studies of triethanolamine in B6C3F1 mice.

Authors:  Y Konishi; A Denda; K Uchida; Y Emi; H Ura; Y Yokose; K Shiraiwa; M Tsutsumi
Journal:  Fundam Appl Toxicol       Date:  1992-01

3.  Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice.

Authors:  J G Fox; F E Dewhirst; J G Tully; B J Paster; L Yan; N S Taylor; M J Collins; P L Gorelick; J M Ward
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

4.  Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species.

Authors:  J M Ward; J G Fox; M R Anver; D C Haines; C V George; M J Collins; P L Gorelick; K Nagashima; M A Gonda; R V Gilden
Journal:  J Natl Cancer Inst       Date:  1994-08-17       Impact factor: 13.506

5.  Evaluation of antibiotic therapies for eradication of Helicobacter hepaticus.

Authors:  C J Foltz; J G Fox; L Yan; B Shames
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

6.  Impact of Helicobacter hepaticus infection in B6C3F1 mice from twelve National Toxicology Program two-year carcinogenesis studies.

Authors:  J R Hailey; J K Haseman; J R Bucher; A E Radovsky; D E Malarkey; R T Miller; A Nyska; R R Maronpot
Journal:  Toxicol Pathol       Date:  1998 Sep-Oct       Impact factor: 1.902

7.  Identification of widespread Helicobacter hepaticus infection in feces in commercial mouse colonies by culture and PCR assay.

Authors:  B Shames; J G Fox; F Dewhirst; L Yan; Z Shen; N S Taylor
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

8.  Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii.

Authors:  A Nomura; G N Stemmermann; P H Chyou; I Kato; G I Perez-Perez; M J Blaser
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

9.  Helicobacter pylori infection and the risk of gastric carcinoma.

Authors:  J Parsonnet; G D Friedman; D P Vandersteen; Y Chang; J H Vogelman; N Orentreich; R K Sibley
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

10.  Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of helicobacter-induced carcinogenesis.

Authors:  J G Fox; X Li; L Yan; R J Cahill; R Hurley; R Lewis; J C Murphy
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

View more
  12 in total

1.  Distance burning: how gut microbes promote extraintestinal cancers.

Authors:  Arlin B Rogers
Journal:  Gut Microbes       Date:  2011 Jan-Feb

2.  Phylogeny of the defined murine microbiota: altered Schaedler flora.

Authors:  F E Dewhirst; C C Chien; B J Paster; R L Ericson; R P Orcutt; D B Schauer; J G Fox
Journal:  Appl Environ Microbiol       Date:  1999-08       Impact factor: 4.792

3.  Helicobacter genus DNA fragments are commonly detectable in bile from patients with extrahepatic biliary diseases and associated with their pathogenesis.

Authors:  Takashi Kobayashi; Kenichi Harada; Koichi Miwa; Yasuni Nakanuma
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

Review 4.  Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases.

Authors:  J V Solnick; D B Schauer
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

Review 5.  Effects of Helicobacter infection on research: the case for eradication of Helicobacter from rodent research colonies.

Authors:  Maciej Chichlowski; Laura P Hale
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

6.  Novel intestinal Helicobacter species isolated from cotton-top tamarins (Saguinus oedipus) with chronic colitis.

Authors:  K E Saunders; Z Shen; F E Dewhirst; B J Paster; C A Dangler; J G Fox
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

7.  SCID/NCr mice naturally infected with Helicobacter hepaticus develop progressive hepatitis, proliferative typhlitis, and colitis.

Authors:  X Li; J G Fox; M T Whary; L Yan; B Shames; Z Zhao
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

8.  Prevalence and spread of enterohepatic Helicobacter species in mice reared in a specific-pathogen-free animal facility.

Authors:  U R M Bohr; M Selgrad; C Ochmann; S Backert; W König; A Fenske; T Wex; P Malfertheiner
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

9.  Helicobacter marmotae sp. nov. isolated from livers of woodchucks and intestines of cats.

Authors:  James G Fox; Zeli Shen; Shilu Xu; Yan Feng; Charles A Dangler; Floyd E Dewhirst; Bruce J Paster; John M Cullen
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

10.  Effects of medicated diet to eradicate Helicobacter spp. on growth, pathology, and infection status in Rag1-/- and nude mice.

Authors:  Caroline M Garrett; Dillon Muth; Julie Watson
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-05       Impact factor: 1.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.